How NIA Membership Opened the Door for InFinite Biotech to Shape the Future of Nanomaterial Risk Assessment
At the May 2026 meeting of the ECHA’s Nanomaterial Expert Group (NMEG), NIA Member Infinite Biotech presented a novel “in-vitro-learned digital twin” platform (InFinite™) designed to predict long-term health effects of nanomaterial exposure using advanced New Approach Methodologies (NAMs) and digital modelling. The platform combines live cellular monitoring, mechanistic modelling, and in silico disease evolution to generate rapid predictions of long-term toxicity while potentially reducing…
Read More




